Maria del Inda

Maria del Mar Inda

UNVERIFIED PROFILE

Are you Maria del Mar Inda?   Register this Author

Register author
Maria del Inda

Maria del Mar Inda

Publications by authors named "Maria del Mar Inda"

21Publications

343Reads

46Profile Views

1PubMed Central Citations

Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.

J Psychopharmacol 2019 Aug 19:269881119864968. Epub 2019 Aug 19.

1 Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269881119864968DOI Listing
August 2019

Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.

Pain Pract 2019 Jul 3. Epub 2019 Jul 3.

Pain Unit, Department of Health of Alicante, Alicante General Hospital, Alicante, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/papr.12816DOI Listing
July 2019

Health benefits of an adverse events reporting system for chronic pain patients using long-term opioids.

Acta Anaesthesiol Scand 2019 02 14;63(2):248-258. Epub 2018 Aug 14.

Pain Unit, Alicante Department of Health-General Hospital, Alicante, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/aas.13243DOI Listing
February 2019

Sleep problems in adults with autism spectrum disorder and intellectual disability.

Autism Res 2019 Jan 1;12(1):66-79. Epub 2018 Oct 1.

Department of Health of Alicante-General Hospital, ISABIAL, Neuropharmacology on Pain (NED) Research Unit, Alicante, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/aur.2000
Publisher Site
http://dx.doi.org/10.1002/aur.2000DOI Listing
January 2019

OPRM1 Gene Interaction with Sleep in Chronic Pain Patients Treated with Opioids.

Pain Physician 2019 01;22(1):97-107

Pain Unit, Health Department of Alicante-General Hospital, Alicante, Spain; Neuropharmacology on Pain (NED), Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain; Clinical Pharmacology Unit, Health Department of Alicante-General Hospital, Alicante, Spain.

View Article

Download full-text PDF

Source
January 2019

OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients.

Ann N Y Acad Sci 2018 May 20. Epub 2018 May 20.

Neuropharmacology on Pain (NED) Research Group, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante-General Hospital, Alicante, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/nyas.13735
Publisher Site
http://dx.doi.org/10.1111/nyas.13735DOI Listing
May 2018

Erectile dysfunction in patients with chronic pain treated with opioids.

Med Clin (Barc) 2017 Jul 22;149(2):49-54. Epub 2017 Feb 22.

Grupo Neurofarmacología aplicada al dolor y diversidad funcional (NED), Hospital General Universitario de Alicante (HGUA), Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-Fundación FISABIO), Alicante, España; Unidad de Farmacología Clínica, Hospital General Universitario de Alicante (HGUA), Alicante, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2016.12.038DOI Listing
July 2017

The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD).

Aging Male 2017 Mar 18;20(1):1-8. Epub 2016 Oct 18.

a Research Unit, Foundation for the Promotion of Health Research and Biomedicine of Valencia (FISABIO) , Alicante , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13685538.2016.1185408DOI Listing
March 2017

Active CREB1 promotes a malignant TGFβ2 autocrine loop in glioblastoma.

Cancer Discov 2014 Oct 1;4(10):1230-41. Epub 2014 Aug 1.

Vall d Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-0275DOI Listing
October 2014

Glioblastoma multiforme: a look inside its heterogeneous nature.

Cancers (Basel) 2014 Jan 27;6(1):226-39. Epub 2014 Jan 27.

Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, 119-129 Passeig Vall d'Hebron, Barcelona 08035, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers6010226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980595PMC
January 2014

Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas.

ISRN Neurol 2012 9;2012:576578. Epub 2012 Jan 9.

Unidad de Biología de Tumores Cerebrales, Universidad de Navarra, 31008 Pamplona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5402/2012/576578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263565PMC
August 2012

Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.

J Exp Med 2011 Dec 12;208(13):2657-73. Epub 2011 Dec 12.

Ludwig Institute for Cancer Research, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20111102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244036PMC
December 2011

Heterogeneity maintenance in glioblastoma: a social network.

Cancer Res 2011 Jun 31;71(12):4055-60. Epub 2011 May 31.

Department of Pathology, University of California, San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-11-0153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117065PMC
June 2011

RASSF1A promoter is highly methylated in primitive neuroectodermal tumors of the central nervous system.

Neuropathology 2007 Aug;27(4):341-6

Unidad de Biología de Tumores Cerebrales, Universidad de Navarra, Pamploma, Spain.

View Article

Download full-text PDF

Source
August 2007